Loading company
BIO KEY International Inc.
BKYI · Nasdaq · ·
$3.12+85.7%Sep 29 close
- 1M
- +1.5%
BKYI · Nasdaq · ·
$3.12+85.7%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1.9M | $1.7M | +13.15% |
| Profit | -$576.9K | -$1.2M | +50.59% |
| Profit per share | -$0.26 | -$0.51 | +49.02% |
| Free Cash Flow | -$845.7K | -$881.5K | +4.05% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
BIO KEY International Inc. has no earnings call transcript available.
Releases land after the close or before the open, so the move is the session that follows.
International, Inc. ( www.BIO-key.com ) BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions. BIO-key
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from BIO KEY International Inc.’s Item 2.02 8-K filed August 14, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.